Health Highlights: Nov. 7, 2022
Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more
Is surgery always necessary for chronic chest pain? A new clinical trial finds patients' overall risk of death is about the same whether they choose aggressive surgical treatment or a more conservative approach focused on medication and lifestyle changes. Read more
Paxlovid might cut odds for long COVID. A new analysis showed people treated with the drug had a 26% reduced risk of developing several long COVID conditions, including heart disease, blood disorders, fatigue and other issues. Read more
Related Posts
Severe COVID May Age Survivors’ Brains 20 Years: Study
FRIDAY, May 6, 2022 (HealthDay News) -- A serious bout of COVID-19 can prompt a...
Biden Administration Moves to Cut Methane Emissions That Threaten Climate, Health
TUESDAY, Nov. 2, 2021 (HealthDay News) -- A new rule to sharply cut methane...
Social Media Is Parents’ Top Concern as Kids Head Back to School: Poll
MONDAY, Aug. 21, 2023 (HealthDay News) -- When U.S. parents express their...
FDA Advisers Meet to Decide Next COVID-19 Booster Shot
WEDNESDAY, June 14, 2023 (HealthDay News) -- COVID-19 boosters may be offered...